A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel.
Journal
European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
12
07
2022
revised:
15
09
2022
accepted:
26
09
2022
pubmed:
18
10
2022
medline:
15
12
2022
entrez:
17
10
2022
Statut:
ppublish
Résumé
Over the past decade, only minor changes have been introduced in the TNM staging system for renal cancer. Conversely, many milestones and modifications in management of the disease have been achieved, especially for patients with locally advanced and metastatic cancers. The European Association of Urology guidelines panel proposes a new TNM classification scheme for staging of renal cell carcinoma to reflect these breakthrough clinical improvements.
Identifiants
pubmed: 36253306
pii: S0302-2838(22)02703-8
doi: 10.1016/j.eururo.2022.09.026
pii:
doi:
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
3-5Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.